| 标题 |
[求助补充材料]
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Yunpeng Yang; Huaqiang Zhou; Lin‐Quan Tang; Sufang Qiu; Yaqian Han; et al 出版日期:2025-10-19 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)